Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment.

@article{Wit2013ManagementOC,
  title={Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment.},
  author={Maike de Wit and Petra Ortner and H G Lipp and Jalid Sehouli and Michael Untch and Markus Ruhnke and Regine Mayer-Steinacker and C Carsten Bokemeyer and Karin Jordan},
  journal={Onkologie},
  year={2013},
  volume={36 3},
  pages={127-35}
}
BACKGROUND Cytotoxic extravasation is a rare but potentially serious and painful complication of intravenous drug administration in oncology. Literature is anecdotal, and systematic clinical trials are scarce. The German working group for Supportive Care in Cancer (ASORS) has prepared an expert opinion for the diagnosis, prophylaxis and management of cytotoxic extravasation based on an interdisciplinary expert panel. MATERIAL AND METHODS A Pubmed search was conducted for diagnosis, risk… CONTINUE READING